German biotech startup Paion has been shepherding through trials a geneticallyengineered version of a protein called desmoteplase, found in the saliva of vampire bats.
Existing drug regimens are based on various geneticallyengineered versions of the natural immune system protein alpha interferon combined with a second chemical, ribavirin.
Among other colossal ambitions, he wants to revitalize the troubled field of gene therapy, make dozens of inexpensive protein drugs and produce better geneticallyengineered crops that will benefit consumers, not just farmers.